Lv670
1758 积分 2024-06-07 加入
2022 5th International Conference on Advances in Biological Science and Technology Selected Abstracts Supplement
9天前
已完结
Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)
1个月前
已完结
CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis
2个月前
已完结
Association of frequent amplification of chromosome 11q13 in esophageal squamous cell cancer with clinical benefit to immune check point blockade
2个月前
已完结
Cyclin D1 Promotes Survival and Chemoresistance By Maintaining ATR and CHEK1 Signaling in TP53-Deficient Mantle Cell Lymphoma Cell Lines
4个月前
已完结
Cyclin D1 Promotes Survival and Chemoresistance By Maintaining ATR and CHEK1 Signaling in TP53-Deficient Mantle Cell Lymphoma Cell Lines
4个月前
已关闭
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment
4个月前
已完结
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment
4个月前
已完结
Oesophageal cancer
4个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
5个月前
已完结
皖公网安备34019202002308
